[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584575":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":18,"responsibleParty":33,"collaborators":7,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":40,"acronym":41,"eligibilityCriteria":42,"healthyVolunteers":37,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":53,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Medical University of Graz","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Gabriel Honnef, MD, PhD","Medical University of Graz, Department of Anaesthesiology","PRINCIPAL_INVESTIGATOR",[14],{"name":10,"role":15,"phone":16,"phoneExt":7,"email":17},"CONTACT","+436509160890","gabriel.honnef@medunigraz.at",[19],{"facility":5,"status":20,"city":21,"state":7,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"RECRUITING","Graz","8043","Austria","AT",{"type":26,"coordinates":27},"Point",[28,29],15.44197,47.06733,{"lat":29,"lon":28},[32],{"name":10,"role":15,"phone":7,"phoneExt":7,"email":17},{"type":34,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100584575","implementation-of-an-empiric-transfusion-bundle-for-out-of-hospital-patients-with-haemorrhagic-shock-100584575",false,"NCT06891131","Implementation of an Empiric Transfusion Bundle for Out of Hospital Patients With Haemorrhagic Shock","Implementation of an Empiric Transfusion Bundle for Out of Hospital Patients With Haemorrhagic Shock: a Prospective Observational Study C-TOP - Coagulation Therapy for Out-of-Hospital Patients","C-TOP","Inclusion Criteria:\n\n* aged, or believed to be aged\n* 18 years or above\n* confirmed or suspected life-threatening bleeding from trauma (i.e. signs of inadequate perfusion of tissues, tachycardia, hypotension, suspected blood loss)\n* need for volume replacement therapy.\n\nExclusion Criteria:\n\n* patient with known recent history of thromboembolic events within the last 6 months\n* known or suspected pregnancy at presentation\n* patient with known refusal of a participation in this clinical trial.","ALL","18 Years",{"count":46,"type":47},10,"ESTIMATED","OBSERVATIONAL","The investigators will evaluate the implementation of a treatment bundle (Fibrinogen, Plasma and Tranexamic Acid)",[51,52],"Haemorrhagic Shock","Trauma Coagulopathy",[54,55,56,57],"Trauma","coagulopathy","haemmorhage","transfusion","2025-12-09",{"date":60,"type":61},"2025-12-17","ACTUAL",{"date":63,"type":61},"2025-06-01",{"date":65,"type":47},"2027-06-01",{"name":5,"class":6},1]